Submission Details
| 510(k) Number | K902462 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 04, 1990 |
| Decision Date | June 21, 1990 |
| Days to Decision | 17 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | — |
K902462 is an FDA 510(k) clearance for the MODIFIED QM300 RHEUMATOID FACTOR TEST, a System, Test, Rheumatoid Factor (Class II — Special Controls, product code DHR), submitted by Kallestad Diag, A Div. of Erbamont, Inc. (Chaska, US). The FDA issued a Cleared decision on June 21, 1990, 17 days after receiving the submission on June 4, 1990. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5775.
| 510(k) Number | K902462 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 04, 1990 |
| Decision Date | June 21, 1990 |
| Days to Decision | 17 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | — |
| Product Code | DHR — System, Test, Rheumatoid Factor |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5775 |